Applied Spectral Imaging

Executive Summary

Applied Spectral Imaging (ASI) is a private company founded in 1993 and headquartered in Carlsbad, California, specializing in digital pathology and cytogenetics solutions. The company offers a comprehensive suite of computer-aided tools for digital cytogenetics, including aided karyotyping and FISH scanning and analysis, as well as a scanner-agnostic digital pathology platform for H&E and IHC with tissue matching to FISH specimens. With over three decades of experience, ASI has established itself as a niche player in the diagnostics and genetics/genomics space, providing integrated workflows that bridge cytogenetics and pathology. Its products enable pathologists and cytogeneticists to digitize, analyze, and manage images efficiently, supporting both routine clinical diagnostics and research applications. While the company remains privately held with no disclosed funding rounds or valuation, its longevity and focus on interoperability (scanner-agnostic) position it well in the growing digital pathology market, which is expected to expand as labs adopt whole-slide imaging and AI-assisted analysis.

Upcoming Catalysts (preview)

• Q2 2026Launch of next-generation AI-powered digital pathology platform65% success
• Q4 2026FDA clearance for automated FISH analysis software50% success
• Q1 2027Strategic partnership with a major pathology lab network40% success